1020656-60-3 Usage
Explanation
The compound's full name, which describes its structure and classification.
Explanation
The compound belongs to a specific class of chemical compounds, which have been found to exhibit various biological activities.
Explanation
The compound is frequently utilized in the field of pharmaceutical research due to its potential applications.
Explanation
Tetrahydropyrrolopyrazines, including this compound, have shown various biological activities, making them interesting for research.
Explanation
The compound has shown promise as a potential drug candidate for treating different medical conditions.
Explanation
The compound's unique molecular structure, consisting of a pyridine ring and a tetrahydropyrrolopyrazine core, contributes to its chemical properties and potential pharmaceutical applications.
Explanation
The compound's unique chemical properties make it suitable for various pharmaceutical applications.
Explanation
Further research is being conducted to better understand the compound's potential uses and its implications in the medical field.
Class
Tetrahydropyrrolopyrazines
Pharmaceutical Research
Commonly used
Biological Activities
Exhibits a wide range
Potential Drug Candidate
For various medical conditions
Molecular Structure
Pyridine ring and a tetrahydropyrrolopyrazine core
Chemical Properties
Unique
Ongoing Research
Exploring potential uses and implications
Check Digit Verification of cas no
The CAS Registry Mumber 1020656-60-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,2,0,6,5 and 6 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1020656-60:
(9*1)+(8*0)+(7*2)+(6*0)+(5*6)+(4*5)+(3*6)+(2*6)+(1*0)=103
103 % 10 = 3
So 1020656-60-3 is a valid CAS Registry Number.
1020656-60-3Relevant articles and documents
Substituted Tetrahydropyrrolopyrazine Compounds and the Use Thereof in the Treatment and/or Inhibition of Pain
-
Page/Page column 17, (2008/12/06)
Substituted tetrahydropyrrolopyrazine compounds corresponding to the formula I: processes for their preparation, pharmaceutical compositions comprising these compounds and the use of these compounds for the treatment and/or inhibition of pain and other disorders or disease states at least partly mediated by KCNQ2/3 K+ channels.
